Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rydberg

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Clinical Pharmacy and Therapeutics|October 1, 1995
Comparison of the kinetics of glyburide and its active metabolites in humansT Rydberg, A Jönsson, A Melander
Clinical Pharmacokinetics|April 16, 1998
Is there a concentration-effect relationship for sulphonylureas?A Melander, R Donnelly, T Rydberg
Journal of Chromatography|March 8, 1991
Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatographyT Rydberg, E Wåhlin-Boll, A Melander
Diabetes Care|September 1, 1994
Hypoglycemic activity of glyburide (glibenclamide) metabolites in humansT Rydberg, A Jönsson, M Røder, et al.
Diabetes, Obesity & Metabolism|March 21, 2002
Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetesA Jönsson, B Hallengren, T Rydberg, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal functionA Jönsson, T Rydberg, G Sterner, et al.
British Journal of Clinical Pharmacology|April 1, 1997
Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamicsT Rydberg, A Jönsson, M O Karlsson, et al.
Pain|March 1, 1992
Cancer pain relief by continuous administration of epidural morphine in a hospital setting and at homeL Ohlsson, T Rydberg, T Edén, et al.
Diabetes Care|February 1, 1994
Slow elimination of glyburide in NIDDM subjectsA Jönsson, T Rydberg, G Ekberg, et al.
Environment International|March 31, 2004
Life cycle assessment part 2: current impact assessment practiceD W Pennington, J Potting, G Finnveden, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Clinical Pharmacy and Therapeutics|October 1, 1995
Comparison of the kinetics of glyburide and its active metabolites in humansT Rydberg, A Jönsson, A Melander
Clinical Pharmacokinetics|April 16, 1998
Is there a concentration-effect relationship for sulphonylureas?A Melander, R Donnelly, T Rydberg
Journal of Chromatography|March 8, 1991
Determination of glibenclamide and its two major metabolites in human serum and urine by column liquid chromatographyT Rydberg, E Wåhlin-Boll, A Melander
Diabetes Care|September 1, 1994
Hypoglycemic activity of glyburide (glibenclamide) metabolites in humansT Rydberg, A Jönsson, M Røder, et al.
Diabetes, Obesity & Metabolism|March 21, 2002
Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetesA Jönsson, B Hallengren, T Rydberg, et al.
European Journal of Clinical Pharmacology|April 29, 1998
Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal functionA Jönsson, T Rydberg, G Sterner, et al.
British Journal of Clinical Pharmacology|April 1, 1997
Concentration-effect relations of glibenclamide and its active metabolites in man: modelling of pharmacokinetics and pharmacodynamicsT Rydberg, A Jönsson, M O Karlsson, et al.
Pain|March 1, 1992
Cancer pain relief by continuous administration of epidural morphine in a hospital setting and at homeL Ohlsson, T Rydberg, T Edén, et al.
Diabetes Care|February 1, 1994
Slow elimination of glyburide in NIDDM subjectsA Jönsson, T Rydberg, G Ekberg, et al.
Environment International|March 31, 2004
Life cycle assessment part 2: current impact assessment practiceD W Pennington, J Potting, G Finnveden, et al.
Pageof 2